logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/08/2025
The Taiwan Stock Exchange Weighted Index closed with little change at 24,158.36.
Latest
2 m ago
"Gold Rush" ignites Ethereum bull market as ETF products attract over 1 billion dollars in a single day.
3 m ago
Hua Wang Motors responds to rumors of Guangzhou Automobile Group E an investment: Currently under further investigation.
4 m ago
"Trump says he may allow Nvidia to sell 'special version' of artificial intelligence chips in China, Foreign Ministry responds."
4 m ago
According to reports, President Trump of the United States stated on Monday that he may allow Nvidia to sell a "special version" Blackwell artificial intelligence chip in China. This version of the chip is likely to have better performance than the previously approved H20 chip for sale to China. Foreign Ministry spokesperson Lin Jian said that specific questions should be directed to the relevant Chinese authorities. China has repeatedly stated its principled position on the issue of American chip exports to China, and hopes that the US will take practical actions to maintain the stability and smooth operation of the global supply chain.
4 m ago
Chinese biopharmaceutical company: TQB3142 clinical trial application accepted by NMPA.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.